Skip to main navigation
  • IR Home
  • News
  • Events & Presentations
  • Governance
    • Our Team
    • Board of Directors
    • Committee Composition
    • Documents & Charters
  • Financials
    • SEC Filings
  • Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

News Releases

Jun 01, 2026
Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
Mar 02, 2026
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
Feb 17, 2026
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
Feb 03, 2026
Rallybio Announces Reverse Stock Split of Common Stock

Investor Tools

Unimagined therapies. Undreamed outcomes.

Rallybio Newsroom
Linkedin Twitter

info@rallybio.com

234 Church Street
New Haven, CT 06510

+1 203-859-3820
+1 475-47-RALLY (72559)

© 2026 Rallybio | Terms of Use | Privacy Policy | Community Guidelines